The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease, overweight or obesity, without diabetes [1] [2]
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
A neural protection racket: AMPK and the GABA(B) receptor
Interestingly, this differential expression correlates with opposing patient outcomes
The longest median time-to-onset was 4 (IQR 040) days for semaglutide, while the shortest was 0 (IQR 011) day for lixisenatide, 1 (IQR 019.75) day for exenatide, 1 (IQR 07) day for dulaglutide, and 3 (IQR 036.75) days for liraglutide, respectively
When the body is overwhelmed by toxins, it uses up its glutathione stores for detoxification, leaving less available for skin support and cellular repair